Fortress Biotech Inc Pref Series A (FBIOP) Stock Analysis

Fortress Biotech Inc Pref Series A (FBIOP) is a publicly traded company in the HEALTHCARE sector. It trades at $20.45, carries a market capitalization of $77.81M. This page summarizes the public market data, fundamentals, and frequently asked questions for FBIOP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Fortress Biotech Inc Pref Series A currently has a Bullish sentiment score of 0.23.

About Fortress Biotech Inc Pref Series A

Fortress Biotech Inc. (FBIOP) is a New York-based biopharmaceutical company dedicated to the development and commercialization of cutting-edge pharmaceutical and biotech products. The company leverages innovative drug development platforms to improve patient care, with a diverse pipeline addressing various therapeutic areas. Fortress's strategic focus on advancing healthcare solutions not only underscores its commitment to enhancing treatment options but also positions it as an attractive inv...

GNG Research Analysis

GNG Research scores Fortress Biotech Inc Pref Series A (FBIOP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FBIOP.

Frequently Asked Questions

Does FBIOP pay dividends?

Fortress Biotech Inc Pref Series A (FBIOP) does not currently pay a regular dividend.

What is FBIOP's market cap?

Fortress Biotech Inc Pref Series A (FBIOP) has a market capitalization of $77.81M with a current stock price of $20.45.